HBR (高出血リスク)：2022年における最適な抗血栓療法アップデート

A professor of division of cardiovascular medicine at Toho University, Ohashi Medical Center, Japan. Features in 1 video on Wondr Medical. Masato Nakamura generally speaks on Gene Therapy, Cell Therapy, Acute Management of Atrial Fibrillation, and Combination of Pacing and Drug Therapy/Ablation.

Dr Takayuki Warisawa is a Consultant Interventional Cardiologist at St. Marianna University School of Medicine Yokohama City Seibu Hospital and Gifu Heart Center in Japan. After graduating with honors from the prestigious University of Tokyo, he concentrated on clinical work, especially in the field of cardiology, emergency medicine, and intensive care. He trained as an interventional cardiologist for five years at New Tokyo Hospital, which is renowned for high-level interventional cardiology and clinical research. There, he developed skill and insight for complex PCI procedure. He had also taken the role of the Director of Emergency Medicine. While working as an expert clinician, he performed many clinical studies focused on the invasive and non-invasive coronary physiology including iFR/FFR, IMR/CFR, Scintigraphy and Perfusion CMR. Many of the studies have been published in international journals and a selection have been awarded at the Japanese scientific congress. Dr Warisawa is very focused and enthusiastic about invasive coronary physiology and is currently collaborating with Dr Justin Davies on several clinical studies, as well as working as a main operator at his cath lab and taking a leading role at his cardiovascular intensive care unit.